Portable Fundus Camera AI-FD16aF Approved Class II Medical Device Registration Certificate A fundus camera designed specifically for retinal screening Airdoc-AIFUNDUS Fast diagnosis and evaluation of diabetic retinopathy, hypertensive retinopathy, retinal vein occlusion, age-related macular degeneration, pathological myopia, and retinal detachment. It has obtained the first Class III Medical Device Registration Certificate for AI-based fundus imaging from the National Medical Products Administration (NMPA). The excellent performance of version 1.0 in diabetic retinopathy diagnosis was demonstrated in a multicenter clinical trial, showing industry-leading sensitivity of 91.75% and specificity of 93.1%. It features automatic quality control for image capture, ensuring effective image quality and assessment. The built-in algorithm is highly adaptable and compatible with various brands and models of fundus cameras. Utilizing retinal image analysis to predict various risk factors, enabling the assessment of dozens of health risk indicators related to cardiovascular system, endocrine and metabolic system, nervous system, and ocular health.